Products

Aiforia
Aiforia
Pathology AI
Aiforia provides deep learning AI solutions for pathology, offering software that enhances diagnostic capabilities in image analysis for medical discoveries. They offer a comprehensive portfolio of high-performance AI solutions for both clinical and preclinical applications, aiming to improve the speed, accuracy, and consistency of analyzing complex medical images. Aiforia's cloud-based platform is used globally by thousands of pathologists, medical scientists, and researchers in over 50 countries. Over 1 million images have been analyzed and thousands of AI models developed using Aiforia's platform.

See all 1 product →

About Aiforia

Aiforia is a leading healthcare AI company specializing in deep learning artificial intelligence solutions for pathology. Their software aims to enhance diagnostic capabilities in image analysis, facilitating medical discoveries and improving patient care. The company provides cloud-based platforms that enable pathologists and researchers to analyze digital pathology images more efficiently and consistently. Aiforia’s solutions are designed to automate routine tasks, streamline diagnostic workflows, and support more standardized image analysis and quantification, addressing challenges like rising diagnostic workloads and specialist shortages.

For physicians, Aiforia offers AI-powered pathology platforms that integrate into existing laboratory infrastructures. Their clinical solutions include AI models for various cancer types, such as breast, lung, and prostate cancer, providing tools for comprehensive analysis and reporting. The Aiforia® Create tool allows users, even without prior AI experience, to develop and validate deep learning AI models for histological features and patterns in image analysis. These solutions are designed to increase the speed, accuracy, and consistency of analyzing large and complex medical images, ultimately aiming to improve diagnostic accuracy and patient outcomes.

Focus Areas

AI-powered pathology image analysis deep learning digital pathology oncology neuroscience preclinical research clinical diagnostics

Business Intelligence

Key InvestorsAscend Capital Partners, Business Finland, Epredia, PHC Holdings Corporation
PartnershipsMayo Clinic, NHS (University Hospital Southampton NHS Foundation Trust), Veneto Region Health Authority (Italy), Siemens Healthineers, Orion, Techcyte, PathPresenter, Google Cloud Marketplace, Microsoft Azure
TechnologyCloud-based, deep learning AI, Vision Transformer architecture, Foundation Engine, image agnostic, integrates with PACS/LIMS

What Physicians Need to Know

Specialization
Aiforia specializes in deep learning AI solutions for digital pathology, aiming to enhance the speed, accuracy, and consistency of analyzing large and complex medical images.
Key Differentiators
Aiforia's key differentiators include its cloud-based platform, which offers image management, visual analysis, and collaboration tools without requiring coding or dedicated hardware. They also offer a versatile AI model portfolio, including CE-IVD certified diagnostic support tools and custom AI model development. A supervised learning approach prioritizes human oversight and expert input, ensuring transparency and reliability.
Technology Stack
Aiforia leverages deep learning AI and cloud-based technology. Their platform is built with a cloud-native architecture designed for the demands of digital pathology, utilizing Microsoft Azure for storage and compute. They have expanded their AI technology platform to include the Vision Transformer architecture and a proprietary Foundation Engine, which uses foundation models pre-trained on vast image datasets combined with pathologist annotations to accelerate AI model development.
Clinical Applications
Aiforia offers clinical suites for various cancer diagnostics, including breast cancer (grading, ER, PR, HER2, Ki67), lung cancer, prostate cancer, colorectal cancer (QuantCRC), gastric cancer (detection of cancer and H. pylori), and lymph node metastasis. Many of these solutions are CE-IVD marked for diagnostic use in EU and EEA countries.
Research Applications
Aiforia's research solutions provide automated study-centric workflows and image analysis applications for various research areas, including toxicopathology and neuroscience. They enable quantification and discoveries by automating repetitive tasks and supporting GLP frameworks.
AI Model Development
Aiforiau00ae Create is a versatile, cloud-based tool for developing, customizing, and validating deep learning AI models for image analysis in digital pathology. It is designed for pathologists and scientists, requiring no data science or programming expertise, and allows for collaborative work in real-time.
Physician Tip

For physicians, Aiforia's tools aim to increase efficiency, consistency, and diagnostic accuracy in pathology by automating repetitive tasks and providing objective, quantitative, and explainable results. The platform's ease of use and cloud-based nature mean pathologists can leverage advanced AI without needing to be data science experts. The supervised deep learning approach ensures human oversight, and the ability to develop custom AI models allows for tailored solutions to specific diagnostic needs. Aiforia's solutions also support comprehensive case-level review and reporting, combining results from multiple AI models and stainings for first-read diagnostic support.

Aiforia emphasizes seamless integration with existing laboratory infrastructure, including LIS, LIMS, PACS, IMS, and scanners, to enable automated and optimal workflows. They offer publicly available API specifications and have a specialized integration team to ensure smooth implementation. Aiforia also partners with other healthcare technology providers like Dedalus and PathPresenter to integrate their AI solutions directly into pathologists' workflows.

Products by Aiforia

1 product in the directory

Aiforia
Aiforia
Pathology AI
Aiforia provides deep learning AI solutions for pathology, offering software that enhances diagnostic capabilities in image analysis for medical discoveries. They offer a comprehensive portfolio of high-performance AI solutions for both clinical and preclinical applications, aiming to improve the speed, accuracy, and consistency of analyzing complex medical images. Aiforia's cloud-based platform is used globally by thousands of pathologists, medical scientists, and researchers in over 50 countries. Over 1 million images have been analyzed and thousands of AI models developed using Aiforia's platform.

What the Web Says

Aiforia receives generally positive feedback for its AI-powered image analysis platform, particularly in pathology and medical research. Users appreciate its user-friendly interface and ability to automate complex tasks, though some note a learning curve and desire for more advanced features. As an employer, Aiforia is viewed positively for its culture and work-life balance.

Overall: Positive

Strengths

  • User-friendly interface for AI model training and deployment
  • Accelerates image analysis and research workflows
  • High accuracy in AI model predictions for various applications
  • Good customer support and responsiveness
  • Positive company culture and work-life balance (employer reviews)
  • Customizable and adaptable to specific research needs

Limitations

  • Steep learning curve for new users, especially those unfamiliar with AI
  • Some users desire more advanced features and customization options
  • Integration with existing systems can be challenging for some organizations
  • Pricing model may be a concern for smaller labs or individual researchers
  • Limited public reviews available on some platforms
  • Specific feature requests sometimes take time to implement

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT News (general industry sentiment), Reddit (limited mentions)

Last updated: 2026-07-01

Videos

News, demos, and interviews about Aiforia.

Loading videos...

Videos load interactively. If none appear, search YouTube for Aiforia →

View all on YouTube

Press & Coverage

Tissuepathology.com
Aiforia launches next-generation AI technology platform
Aiforia announced the expansion of its AI technology platform, featuring the Vision Transformer architecture and a new Foundation Engine for rapid and cost-efficient AI model development and image analysis.
2025-12
Microsoft Partner
Aiforia brings AI-assisted lung cancer analysis to NHS pathology - Microsoft Partner
Aiforia is collaborating with University Hospital Southampton NHS Foundation Trust to implement AI-assisted lung cancer analysis on Microsoft Azure, aiming to improve efficiency and consistency in diagnostic workflows.
2026-06
Aiforia
Aiforia delivers AI-powered digital pathology solutions through Google Cloud Marketplace
Aiforia's clinical software solutions for AI-powered pathology image analysis are now available on Google Cloud Marketplace, aiming to simplify procurement for pathology labs using Google Cloud.
2024-05
Aiforia
Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology
Aiforia and Techcyte are collaborating to integrate AI algorithms into Techcyte's Fusion platform, aiming to provide fully integrated, AI-powered digital pathology workflows to laboratories globally.
2025-03
Aiforia
Aiforia partners with PathPresenter to accelerate the adoption of digital pathology and AI
Aiforia has partnered with PathPresenter to accelerate the adoption of digital pathology and AI, aiming to democratize access to AI-powered solutions for medical institutions.
2025-03
Aiforia
Aiforia Announces Closing of u20ac17.5M Series B Funding Round
Aiforia completed a u20ac17.5M Series B funding round, led by Epredia's UK entity, a subsidiary of PHC Holdings Corporation, to accelerate the development and commercialization of its AI solutions.
2021-09
Aiforia
Looking back on 2023: A year of important milestones - Aiforia
Aiforia's CEO, Jukka Tapaninen, highlighted key achievements in 2023, including deployments of clinical AI solutions at Mayo Clinic and NHS, selection as an AI provider for the PathLAKE Plus consortium, and a u20ac7.3 million funding decision from Business Finland.
2023-12
MFN.se
Aiforia Technologies Plc's Financial Statements Bulletin for Januaryu2013December 2024: Aiforia's market position and orderbook strengthened
Aiforia's financial statements for 2024 showed significant growth in demand for its AI-assisted image analysis solutions, with the order book increasing by 118%.
2025-03

Frequently Asked Questions

Aiforia offers AI-powered solutions primarily for pathology image analysis, aiming to increase speed, accuracy, and consistency in diagnostics. Their clinical suites cover areas like breast, prostate, lung, colorectal, and gastric cancers, as well as lymph node metastasis detection. These solutions provide AI-supported image-based diagnostics with intelligent visualization, assisted screening, and reporting tools within a cloud-based platform. Aiforia also provides 'Aiforiau00ae Create', a tool for developing custom deep learning AI models for various image analysis applications, which can be used for both research and clinical practice.
Aiforia prioritizes data privacy and security, holding several globally relevant quality and security certifications. They have designed and implemented security practices to comply with HIPAA (Health Insurance Portability and Accountability Act) regulations, with an independent audit firm evaluating their controls for HIPAA Security Rule compliance. Additionally, Aiforia has obtained IVDR (In Vitro Diagnostic Regulation) certification, demonstrating that their clinical solutions meet stringent safety, performance, and risk management requirements for diagnostic medical devices in the European Union.
Aiforia offers a scalable business model based on Software as a Service (SaaS). The cost of using Aiforia's software is dependent on factors such as the number of images, the complexity of the analysis, and the amount of cloud storage and user numbers. They offer both annual and usage-based fees. For a specific quote, Aiforia recommends booking a demo to discuss individual needs.
Aiforia provides dedicated support representatives from their team of scientists who work closely with customers, offering proactive guidance and assistance with challenges. Users also gain access to the Aiforia Community, a digital space for peer interaction, a knowledge base with documentation, and tips for annotation and image analysis. Their cloud-based platform is designed for ease of use, requiring no coding or dedicated hardware, and their science team supports AI model development and deployment.
Aiforia has a vast network of partners, including collaborations with Siemens Healthineers, PathPresenter, Dedalus Group, Sectra, and Proscia. These partnerships aim to expand the availability of Aiforia's AI solutions, integrate them into existing laboratory infrastructures and information systems (like LIS and IMS), and provide comprehensive digital pathology workflows. This allows clients to seamlessly access and utilize Aiforia's AI solutions, enhancing diagnostic capabilities and streamlining workflows.
Founded in 2013, Aiforia is a publicly traded company headquartered in Helsinki, Finland, with subsidiaries in the United States and France, and representatives across Europe and North America. They have a global presence with thousands of users in over 50 countries, and over 1 million images have been analyzed on their platform. Aiforia emphasizes its commitment to continuously integrating the latest AI advancements into clinical practice through its Foundation Engine technology.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.